Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload

Int J Hematol. 2009 May;89(4):546-548. doi: 10.1007/s12185-009-0310-9. Epub 2009 Apr 14.

Authors

Toru Kiguchi¹, Yoshikazu Ito¹, Yukihiko Kimura¹, Kazuma Ohyashiki²

Affiliations

¹ Division of Hematology, First Department of Internal Medicine, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku, Tokyo, 160-0023, Japan.
² Division of Hematology, First Department of Internal Medicine, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku, Tokyo, 160-0023, Japan. ohyashik@rr.iij4u.or.jp.

PMID: 19363706
DOI: 10.1007/s12185-009-0310-9

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anemia, Aplastic / drug therapy*
Benzoates / pharmacology*
Deferasirox
Female
Heart / drug effects*
Heart / physiology*
Humans
Iron Chelating Agents / pharmacology*
Iron Chelating Agents / therapeutic use*
Magnetic Resonance Imaging
Triazoles / pharmacology*
Young Adult

Substances

Benzoates
Iron Chelating Agents
Triazoles
Deferasirox